Cargando…
The role of ECMO in COVID‐19: Can it provide rescue therapy in those who are critically ill?
Arising from the city of Wuhan, Hubei province in China, a novel coronavirus named severe acute respiratory syndrome coronavirus 2 has been rapidly spreading since its first presentation in late 2019. The World Health Organization declared a pandemic on the 11th March 2020, and as of 29th of April 2...
Autores principales: | Savarimuthu, Sugeevan, BinSaeid, Jalal, Harky, Amer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280692/ https://www.ncbi.nlm.nih.gov/pubmed/32442347 http://dx.doi.org/10.1111/jocs.14635 |
Ejemplares similares
-
The need to manage the risk of thromboembolism in COVID-19 patients
por: Khan, Inayat Hussain, et al.
Publicado: (2020) -
Use of ECMO in Patients With Coronavirus Disease 2019: Does the Evidence Suffice?
por: Alom, Samiha, et al.
Publicado: (2021) -
Health benefit and economic impact of utilising ECMO in COVID-19 patients: patient or cost first
por: Butt, Sundas, et al.
Publicado: (2023) -
Cytokine Adsorption in Critically Ill Patients Requiring ECMO Support
por: Lother, Achim, et al.
Publicado: (2019) -
Shedding light on those who provide support
por: Loissel, Elsa
Publicado: (2020)